aflibercept 8 mg PFS
VGFTe-HD-OD-22105
Phase 3 small_molecule completed
Quick answer
aflibercept 8 mg PFS for Diabetic Macular Edema (DME) is a Phase 3 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Diabetic Macular Edema (DME)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed